-
The competing risk approach for prediction of preeclampsia.
Wright D, Wright A, Nicolaides KH.
Am J Obstet Gynecol 2020;223:12-23.e7. pdf -
Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A, Wright A, Syngelaki A, Maritsa VA, Da Silva AB, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;56:400-407. pdf -
Prediction of pre-eclampsia in twin pregnancies by maternal factors and biomarkers at 11-13 weeks' gestation: data from the EVENTS trial.
Benkő Z, Wright A, Rehal A, Cimpoca B, Syngelaki A, Delgado JL, Tsokaki T, De Alvarado M, Vojtassakova D, Malligiannis Ntalianis K, Chaveeva P, Del Campo A, De Ganzo T, Resta C, Atanasova V, Accurti V, Villalain C, Aguilera J, Dojcinovska D, O'gorman N, Plasencias W, Zingler E, Dutemeyer V, Alvar B, Casanova MC, Nicolaides KH.
Ultrasound Obstet Gynecol 2021;57:257-265 pdf -
Mini-combined test compared with NICE guidelines for early risk-assessment for pre-eclampsia: the SPREE diagnostic accuracy study.
Poon LC, Wright D, Thornton S, Akolekar R, Brocklehurst P, Nicolaides KH.
Southampton (UK): NIHR Journals Library 2020 pdf -
Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening.
Khan N, Andrade W, De Castro H, Wright A, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;55:50-57. pdf -
Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery.
Sharabi-Nov A, Kumar K, Fabjan Vodušek V, Premru Sršen T, Tul N, Fabjan T, Meiri H, Nicolaides KH, Osredkar J.
Fetal Diagn Ther 2020;47:471-484. pdf -
Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation.
Wright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH.
Am J Obstet Gynecol 2019;220:197.e1-197.e11. pdf -
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M.
Int J Gynaecol Obstet 2019;Suppl 1:1-33. pdf -
Predictive performance of the competing risk model in screening for preeclampsia.
Wright D, Tan MY, O'Gorman N, Poon LC, Syngelaki A, Wright A, Nicolaides KH.
Am J Obstet Gynecol 2019;220:199.e1-199.e13. pdf -
Good clinical practice advice: First trimester screening and prevention of pre-eclampsia in singleton pregnancy.
FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine.
Int J Gynaecol Obstet 2019;144:325-329. pdf -
Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, Akolekar R, Konstantinidou L, Tsavdaridou M, Galeva S, Ajdacka U, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright A, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;52:186-195. pdf -
Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;52:52-59. pdf -
Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
Litwinska M, Syngelaki A, Wright A, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;52:365-372. pdf -
Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
Tan MY, Wright D, Syngelaki A, Akolekar R, Cicero S, Janga D, Singh M, Greco E, Wright A, Maclagan K, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;51:743-750. pdf -
ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm.
Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;51:738-742. pdf -
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit.
Wright D, Rolnik DL, Syngelaki A, de Paco Matallana C, Machuca M, de Alvarado M, Mastrodima S, Tan MY, Shearing S, Persico N, Jani JC, Plasencia W, Papaioannou G, Molina FS, Poon LC, Nicolaides KH.
Am J Obstet Gynecol 2018;218:612.e1-612.e6. pdf -
Protocol for the prospective validation study: 'Screening programme for pre-eclampsia' (SPREE)
Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LCY.
Ultrasound Obstet Gynecol 2017;50:175-179. pdf -
First-trimester screening for pre-eclampsia: time to act.
Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:663-664. pdf -
Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:589-595. pdf -
ASPRE trial: performance of screening for preterm pre-eclampsia.
Rolnik DL, Wright D, Poon LCY, Syngelaki A, O'Gorman N, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:492-495. pdf